Brief: Lisata Therapeutics To Be Acquired By Kuva Labs For $4.00 Per Share In An All-Cash Tender Offer
21/01/2026 12:06
Jan 21 (Reuters) - Lisata Therapeutics Inc LSTA.O: LISATA THERAPEUTICS ENTERS INTO TERM SHEET TO BE ACQUIRED BY KUVA LABS FOR $4.00 PER SHARE IN AN ALL-CASH TENDER OFFER Source text: ID:nGNX31bNYF Further company coverage: LSTA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal